25 series
Export
<<< of 2>>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterJoanna Achinger-Kawecka
GSE216987
Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions [Promoter Capture Hi-C]
8 Joanna Achinger-Kawecka Aug 08, 2023
GSE216988
Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions [RNA-seq]
8 Joanna Achinger-Kawecka Aug 08, 2023
GSE216986
Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions [EPIC]
8 Joanna Achinger-Kawecka Aug 07, 2023
GSE216989
Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions
24 Joanna Achinger-Kawecka Aug 07, 2023
GSE237768
Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer [WGBS]
8 Joanna Achinger-Kawecka Jul 24, 2023
GSE237769
Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer [CUT&RUN]
13 Joanna Achinger-Kawecka Jul 24, 2023
GSE171066
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [methylation GAR15-13]
8 Joanna Achinger-Kawecka Dec 12, 2021
GSE171069
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [methylation HCI-005]
8 Joanna Achinger-Kawecka Dec 12, 2021
GSE171070
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [ChIP-seq]
23 Joanna Achinger-Kawecka Dec 12, 2021
GSE171071
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [HiC]
6 Joanna Achinger-Kawecka Dec 12, 2021
GSE171072
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [PCHiC]
6 Joanna Achinger-Kawecka Dec 12, 2021
GSE171073
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [RNA-seq]
16 Joanna Achinger-Kawecka Dec 12, 2021
GSE171074
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
88 Joanna Achinger-Kawecka Dec 12, 2021
GSE150252
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer
12 Joanna Achinger-Kawecka Feb 10, 2021
GSE118711
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [ChIP-seq]
14 Joanna Achinger-Kawecka Dec 11, 2019
GSE118712
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [Hi-C]
9 Joanna Achinger-Kawecka Dec 11, 2019
GSE118713
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq]
9 Joanna Achinger-Kawecka Dec 11, 2019
GSE118714
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [WGBS]
3 Joanna Achinger-Kawecka Dec 11, 2019
GSE118715
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [WGS]
5 Joanna Achinger-Kawecka Dec 11, 2019
GSE118716
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer
40 Joanna Achinger-Kawecka Dec 11, 2019